past Webinars
Accelerating kidney disease clinical trials: The power of data driven patient recruitment
sponsored by
Natera
Accelerating discovery in targeted protein degradation: Innovative approaches to degrader screening
sponsored by
Bio Techne
Accelerating drug discovery with an end-to-end imaging data management platform
sponsored by
Flywheel
From AI to IRA to GLP-1s: Unpacking the major healthcare trends at #JPM2025
sponsored by
Real Chemistry
Gene therapy assays: Achieving regulatory compliance with a unified immunogenicity strategy
sponsored by
Precision for Medicine
FAPI-PET imaging & theranostics: A new era in targeting cancer and fibrotic diseases
sponsored by
Perceptive, Lantheus
Post-ESMO review: How molecular residual disease testing is transforming cancer care and drug development
sponsored by
Natera
Mitigating risk in mRNA manufacturing when transitioning from preclinical to clinical
sponsored by
TriLink BioTechnologies
Unlocking biotech’s potential: Strategies for navigating public and private market investments
sponsored by
RBC Capital Markets
Visual biology AI neural network recognize disease signatures in cellular pathway visualizations
sponsored by
Anima Biotech
The power of antigen-specific TCR signatures in developing next-gen immunotherapies
sponsored by
Adaptive
Lessons from the Real World: Journey from Claims to EHR Data in Real-World Evidence Generation
sponsored by
Verana Health
ASCO24 Summary: Latest data on ctDNA as a patient selection and early efficacy marker in drug development
sponsored by
Natera
Clinical trials agility: Tips for adapting to study changes and unexpected events
sponsored by
Advarra
Utilizing novel icIEF fractionation and mass spec for the charge characterization of biotherapeutics
sponsored by
Bio-Techne
New ASCO data: Early detection with WGS-based ctDNA tracking up to 1800 variants
sponsored by
Personalis
Case study: Marketing to HCPs using data-based omnichannel segmentation
sponsored by
Definitive Healthcare
Venture capital velocity: What’s driving renewed momentum in biotech
sponsored by
RBC Capital Markets
How real-world research can streamline post-marketing studies in oncology
sponsored by
Flatiron Health
Enabling Adaptive Clinical Trials through Integrated Development and Manufacturing Solutions
sponsored by
Catalent
Enhance your long-term cell & gene therapy success with pDNA manufacturing solutions
sponsored by
Aldevron
Navigating Policy, Funding, CMC and Regulatory Dynamics for Successful Orphan Drug Development
sponsored by
Catalent
Leveraging large-scale mRNA biology data to advance disease understanding
sponsored by
Anima Biotech
3 things every life sciences company should know before leveraging AI to generate real-world evidence
sponsored by
Verana Health
Navigating the clinical AI landscape & charting your path to precision medicine
sponsored by
Mendel AI, Unlearn
7 questions gene therapy developers should ask their CDMO (and what they will ask you!)
sponsored by
Forge Biologics
Untapped potential: Integrating MRD testing to track diffuse large B-cell lymphoma in clinical trials and in the clinic
sponsored by
Adaptive
Post-SABCS summary & year in review: ctDNA in drug development for breast cancer
sponsored by
Natera
Advertising with Endpoints: Our publisher's take on success stories of 2023
organized by
Endpoints News
Advancing Non-Small Cell Lung Cancer drug discovery and treatment with clinicogenomics
sponsored by
Optum
High Lp(a): The unmet need and value of an expansive drug development landscape
sponsored by
Silence Therapeutics
Data-based strategies for successful digital health technology (DHT) clinical trials
sponsored by
Medrio
Oncology case studies: How two life sciences companies applied real-world evidence to drive innovation
sponsored by
Flatiron
Unlocking insight from health data with healthcare-specific AI that thinks like a physician
sponsored by
Mendel
Actionable data: Challenges, solutions and case studies across pharma research
sponsored by
DNAnexus
A roadmap to earlier efficacy predictors and drivers in cell therapy development
sponsored by
Adaptive
Harnessing cell power: Targeted protein degraders’ potential in combating disease
sponsored by
Arvinas
Targeted Protein Degraders – Key Strategies to Maximize VC Funding and Clinical Success
sponsored by
Catalent
De-risking clinical development and driving therapeutic innovation: The power of RWD from EHRs
sponsored by
Truveta
Cryo-electron microscopy is revolutionizing rational drug discovery pipelines
sponsored by
Thermo Fisher
How immune repertoire sequencing is addressing unmet needs in multiple sclerosis drug development
sponsored by
Adaptive
Alzheimer’s disease: Using deep human biology learning to guide next-generation treatments
sponsored by
Eisai
Harnessing the power of antigen specific T-cell responses to improve vaccine development
sponsored by
Adaptive
Pharma can target ultra-rare conditions — the next step is financing them
organized by
Endpoints News
Post-ASCO Summary: ctDNA as a patient selection and early efficacy marker in drug development
sponsored by
Natera
Accelerating all phases of the immuno-oncology drug development pipeline via immunosequencing
sponsored by
Adaptive
Transforming clinical research: Scaling real-world data across diseases with expert-led AI
sponsored by
Truveta
The connected lab: maximizing the intersection of science and data
sponsored by
TetraScience Deloitte AWS
How to assess the quality of AI output when structuring unstructured medical data
sponsored by
Mendel AI
Targeted Protein Degraders: Through the Lens of the Innovation, Developability, and CMC Challenges
sponsored by
Catalent
The AI drug-discovery revolution: How NYC is prepared to lead
sponsored by
NYC Economic Development Corporation
When to call it quits: VCs making tough decisions in a tough market
sponsored by
RBC Capital Markets
A novel 3D approach to imaging gene therapy expression and vector biodistribution
sponsored by
Invicro, Emit Imaging
Beyond AAV: Prepare for the next generation of advanced therapy delivery
sponsored by
Center for Breakthrough Medicines
New data: ctDNA as a prognostic and predictive biomarker in early-stage gastrointestinal cancers
sponsored by
Natera
Expediting drug product development and commercialization in global markets with global filing strategies
sponsored by
WuXi AppTec
Endpoints' most popular content this year – an exclusive view for marketers
organized by
Endpoints News
New data: Predict breast cancer treatment response and recurrence risk with ctDNA
sponsored by
Natera
Weird and wonderful case studies: Real-world solutions for unexpected bioanalytical challenges
sponsored by
Agilex Biolabs
Patient need for novel therapies in ROS1 fusion-positive non-small cell lung cancer
sponsored by
AnHeart Therapeutics
Navigating industry challenges to drive sustainable Plasmid DNA strategies
sponsored by
Charles River
Lessons learned in bringing novel options for rare liver diseases to patients and families
sponsored by
Albireo Pharma
The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval
sponsored by
Novotech
Advanced dosage forms: Tackling drug delivery challenges & addressing patient needs
sponsored by
Catalent
The evaluation of pan-cancer and oncoReveal™ CDx panels to support localized NGS testing
sponsored by
Pillar Biosciences
A journey without a map: lessons in building an oncology powerhouse where innovation thrives
sponsored by
Astellas
Changing the paradigm for colorectal cancer: Clinical practice & drug development
sponsored by
Natera
A crisis in rare disease: How the current investment landscape is stifling rare disease development
sponsored by
Precision Medicine
Integrated clinical development and supply: Breaking down the early-development journey of a small molecule
sponsored by
Catalent
Identify and quantify point mutations in circulating tumour DNA: The ddPCR approach™
sponsored by
Agilex Biolabs
New data: How ctDNA is evolving oncology patient management and drug development
sponsored by
Natera
Accelerating first-in-class and best-in-class programs using a large-scale digital chemistry strategy
sponsored by
Schrödinger
Applying machine learning to increase clinical trial efficiency: a regulatory journey
sponsored by
Unlearn
R&D changemakers: Building Resilience’s digital infrastructure for a modern R&D team
sponsored by
Benchling
Diagnostics from digital pathology: an AI solution to accelerate precision medicine
sponsored by
OWKIN
Navigating your biopharma drug candidate through early and mid-stage clinical trials
sponsored by
Catalent
Using external data to accelerate randomized controlled trials without introducing bias
sponsored by
Unlearn
mHealth innovation: identifying the best patient-centered technology for your trial needs
sponsored by
Parexel
Changing the game: an examination of cutting-edge novel oncology screening tools
sponsored by
Charles River
A new class of startups is scouting for deals - on both sides of the Pacific
organized by
Endpoints News
Can changing one step change everything? Replacing your polishing step with a single-use solution
sponsored by
3M
Non-clinical and clinical pathways for rapid vaccine development in Australia
sponsored by
Agilex Biolabs
The neurosciences comeback: After a lengthy chill, Big Pharma is warming back up to neuro
organized by
Endpoints News
Essential strategies for gene therapy - from assay development to CDx commercialization
sponsored by
Precision Advance
Innovation in drug product manufacturing: how do we bring new therapies to patients faster?
sponsored by
Cytiva
Life science SPACs – the future of IPOs/crossover investing? A look at 2021/2022
sponsored by
Back Bay Life Science Advisors
Reinventing Harvest Technology: Single-stage chromatography clarification for recombinant protein therapeutic manufacturing
sponsored by
3M
Are we ready for the medicines of tomorrow? Creating the infrastructure for the era of genomic medicine
sponsored by
Sangamo Therapeutics
Plasmid DNA Insights: Expanded focus on CMC in gene & cell therapy development
sponsored by
Aldevron
Transformative approaches to clinical development: Scaling adoption across the industry
sponsored by
Deloitte
Hot topics in Immunoassay Bioanalysis - navigating the immunogenicity and biomarker requirements for clinical trials
sponsored by
Agilex Biolabs
The Great Debate: Internal vs. external manufacturing for advanced therapies
sponsored by
Precision Medicine Group
Predict placebo response using patient psychology to increase trial power
sponsored by
Tools4Patient
Can sponsors collect data in Expanded Access (EAPs) and Named Patient Programs (NPPs)?
sponsored by
WEP Clinical
Clinical trial diversity in the Covid-19 era — are we seeing a paradigm shift?
organized by
Endpoints News
Flattening the 'valley of death:' New tools in the hunt for better preclinical R&D
organized by
Endpoints News
Patient-First R&D: Why the patient experience should be at the center of clinical trial design
sponsored by
AbbVie
Enabling multidimensional tumor immunogenomics for advancing biomarker discovery
sponsored by
Personalis
Breakthrough Technologies to Accelerate Biologic Drug Discovery, Cell Line Development and Biomanufacturability
sponsored by
AbSci
How the World’s First Biolabs Client Portal GALEXI™ Delivers Real-Time Study Management for Biotechs
sponsored by
Agilex Biolabs
Optimizing Direct-to-Patient Clinical Supply for Decentralized Clinical Trials
sponsored by
Catalent
Innovation in Clinical Research: AI-based Drug Development Tools and the Regulatory Landscape
sponsored by
Unlearn.AI
R&D in an age of Covid-19: Tackling the key issues around starting, or restarting an early-stage study
sponsored by
Egnyte
New Platform for Target-to-Hit: From Fragment Screen to Structure-based Drug Discovery
sponsored by
WuXi AppTec
Why Australia is the World’s Leading Early Phase Destination – Rapid Start-up, No IND Required, and a Government-Backed Refund on Almost Half of all Trial Costs
sponsored by
Agilex Biolabs
The Transformation of Clinical Trial Design and Operations: A Panel Discussion on COVID-19 as a Catalyst for Decentralized Trials
sponsored by
PPD
When cell and gene therapies surge to market, how resilient will your cell sourcing infrastructure be?
sponsored by
Be The Match
The Australian Early Phase Biosimilars Clinical Trial Landscape - How Agilex Biolabs and Nucleus Network Work Together
sponsored by
Agilex Biolabs
A Clinical Investigator’s Perspective: Novel Oncology Therapy During & Beyond the COVID Pandemic
sponsored by
Worldwide Clinical Trials
Improving Clinical Trial Quality with Best Practices for E-Clinical Technology
sponsored by
Medidata
ctDNA as a biomarker for monitoring treatment response and molecular recurrence in early-stage and metastatic cancers
sponsored by
Natera
